Colgate Palmolive (CL)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-10 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: COLGATE PALMOLIVE CO (CL) CIK: 0000021665 --- Reporting Owner --- Name: Hazlin John CIK: 0002072169 Role: Officer (Chief Growth Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-10 | Code: M (Exercise of derivative) Shares: +20,989 | Price: $76.41 Total Value: $1,603,769.49 Shares Owned After: 38,634 | Ownership: D (Direct) Footnotes: [F1] Exercise of stock options awarded under the issuer's incentive compensation plan. [Transaction #2] Security: Common Stock Date: 2026-02-10 | Code: S (Open market sale) Shares: -20,989 | Price: $94.25 Total Value: $1,978,211.15 Shares Owned After: 17,645 | Ownership: D (Direct) Footnotes: [F2] Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. [F3] Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.19 to $94.30 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-02-10 | Code: M (Exercise of derivative) Shares: -20,989 | Price: $0.00 Exercisable: N/A | Expires: 2028-09-10 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] Exercise of stock options awarded under the issuer's incentive compensation plan. [F4] Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: Exercise of stock options awarded under the issuer's incentive compensation plan. F2: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.19 to $94.30 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date. --- Signature --- /s/ /s/ Kristine Hutchinson, Attorney-in-Fact (2026-02-12)